China Expands its EV Footprint on the World Stage

As Chinese automobile manufacturer Geely, the parent company behind Volvo and Daimler AG, plans to launch its sub-brand of luxury electric vehicles, a possible competitor to Tesla’s growing footprint, the country appears poised to dominate the EV industry.

Since the early ‘90s, China has ramped up its annual automobile production capacity. In 2001, after joining the World Trade Organization, it increased its production significantly, and today, based on 2019 research from the global trade group, International Organization of Motor Vehicle Manufacturer, or OICA, and 2020 research from Statista, China remains the world’s forerunner, producing nearly 26 million cars in 2020. Now, the focus is on scaling electric vehicle manufacturing, producing autos with the latest technology.

Host Daniel Litwin, the voice of B2B at MarketScale, was joined by Qasim Khan, Deputy Manager of EqualOcean, a China-focused investment research firm with a concentration on China’s innovation, to talk about the investment policies that have allowed the country to scale its booming EV production, plus what the future holds for China and the global supply chain.

 

In his role at EqualOcean, Khan oversees the coverage of the auto and consumer sectors. Litwin hosts and produces podcasts with industry and thought leaders. Together they offer a world of insights on the topic of China’s EV expansion.

“If we look at action specifically around the EV market, much of China’s recent market growth could be attributed to China’s Climate Policy policy action to encourage EV use and manufacturing,” said Khan, referring to initiatives such as EV consumer subsidies, new energy vehicle mandates and credits, and over 500,000 public EV charging outlets.

And since 2018, China has moved its auto production industry onto the world stage, allowing international players like Tesla, Volkswagon, and BMW to expand their manufacturing footprint in China.

Questions remain as to how China is positioning itself to maximize those investments, and whether more international partnerships are on the table.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

TheAIAudit
Introducing TheAIAudit: A Platform Built to Measure, Monitor, and Govern Enterprise AI
May 22, 2026

Enterprise AI is advancing faster than most companies can govern it. Behind the scenes, AI systems are already influencing decisions tied to revenue, operations, compliance, customer outcomes, and risk — yet many organizations still lack a clear way to measure, explain, or oversee what those systems are doing. That is the gap TheAIAudit was…

Read More
Leadership
How the Future of Work Is Being Reshaped by AI, Human Creativity, and Customer-Centered Leadership
May 21, 2026

As artificial intelligence rapidly reshapes industries, many professionals are asking the same urgent question: what happens when AI starts replacing not just repetitive tasks, but the foundational entry-level roles that once launched careers? According to Goldman Sachs Research, AI could expose the equivalent of 300 million jobs globally to automation, while potentially automating tasks…

Read More
finance
Dr. Silver Kung’s Path From $10 Million in Debt to a Multibillion-Dollar Finance Career
May 21, 2026

Global finance is being tested by forces that no balance sheet can fully predict: unstable supply chains, geopolitical shocks, tighter credit conditions and the accelerating rise of AI. In trade finance especially, success depends on more than capital; it requires judgment, discipline and the ability to see risk before it becomes disruption. As automation…

Read More
specialty pharmacy
At the Center of Care: How Specialty Pharmacy Aligns Patients, Providers, and Payers
May 21, 2026

As healthcare costs continue to rise, more patients are finding themselves navigating not just illness, but the growing complexity of paying for treatment. Specialty pharmacy sits right at the center of that challenge—often out of sight, but increasingly essential to how modern care actually works. These high-cost, high-touch therapies now make up more than…

Read More